Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Inhibition of F1 -ATPase from Trypanosoma brucei by its regulatory protein inhibitor TbIF1

O. Gahura, B. Panicucci, H. Váchová, JE. Walker, A. Zíková,

. 2018 ; 285 (23) : 4413-4423. [pub] 20181017

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028170

Grantová podpora
MC_U105663150 Medical Research Council - United Kingdom
MC_EX_MR/M009858/1 Medical Research Council - United Kingdom

E-zdroje Online Plný text

NLK Free Medical Journals od 2005 do Před 1 rokem
Medline Complete (EBSCOhost) od 2005-01-01 do Před 1 rokem
Wiley Free Content od 2005 do Před 1 rokem

Hydrolysis of ATP by the mitochondrial F-ATPase is inhibited by a protein called IF1 . In the parasitic flagellate, Trypanosoma brucei, this protein, known as TbIF1 , is expressed exclusively in the procyclic stage, where the F-ATPase is synthesizing ATP. In the bloodstream stage, where TbIF1 is absent, the F-ATPase hydrolyzes ATP made by glycolysis and compensates for the absence of a proton pumping respiratory chain by translocating protons into the intermembrane space, thereby maintaining the essential mitochondrial membrane potential. We have defined regions and amino acid residues of TbIF1 that are required for its inhibitory activity by analyzing the binding of several modified recombinant inhibitors to F1 -ATPase isolated from the procyclic stage of T. brucei. Kinetic measurements revealed that the C-terminal portion of TbIF1 facilitates homodimerization, but it is not required for the inhibitory activity, similar to the bovine and yeast orthologs. However, in contrast to bovine IF1 , the inhibitory capacity of the C-terminally truncated TbIF1 diminishes with decreasing pH, similar to full length TbIF1 . This effect does not involve the dimerization of active dimers to form inactive tetramers. Over a wide pH range, the full length and C-terminally truncated TbIF1 form dimers and monomers, respectively. TbIF1 has no effect on bovine F1 -ATPase, and this difference in the mechanism of regulation of the F-ATPase between the host and the parasite could be exploited in the design of drugs to combat human and animal African trypanosomiases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028170
003      
CZ-PrNML
005      
20190819095918.0
007      
ta
008      
190813s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/febs.14672 $2 doi
035    __
$a (PubMed)30288927
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Gahura, Ondřej $u Institute of Parasitology, Biology Centre Czech Academy of Science, České Budějovice, Czech Republic. The Medical Research Council Mitochondrial Biology Unit, University of Cambridge, UK.
245    10
$a Inhibition of F1 -ATPase from Trypanosoma brucei by its regulatory protein inhibitor TbIF1 / $c O. Gahura, B. Panicucci, H. Váchová, JE. Walker, A. Zíková,
520    9_
$a Hydrolysis of ATP by the mitochondrial F-ATPase is inhibited by a protein called IF1 . In the parasitic flagellate, Trypanosoma brucei, this protein, known as TbIF1 , is expressed exclusively in the procyclic stage, where the F-ATPase is synthesizing ATP. In the bloodstream stage, where TbIF1 is absent, the F-ATPase hydrolyzes ATP made by glycolysis and compensates for the absence of a proton pumping respiratory chain by translocating protons into the intermembrane space, thereby maintaining the essential mitochondrial membrane potential. We have defined regions and amino acid residues of TbIF1 that are required for its inhibitory activity by analyzing the binding of several modified recombinant inhibitors to F1 -ATPase isolated from the procyclic stage of T. brucei. Kinetic measurements revealed that the C-terminal portion of TbIF1 facilitates homodimerization, but it is not required for the inhibitory activity, similar to the bovine and yeast orthologs. However, in contrast to bovine IF1 , the inhibitory capacity of the C-terminally truncated TbIF1 diminishes with decreasing pH, similar to full length TbIF1 . This effect does not involve the dimerization of active dimers to form inactive tetramers. Over a wide pH range, the full length and C-terminally truncated TbIF1 form dimers and monomers, respectively. TbIF1 has no effect on bovine F1 -ATPase, and this difference in the mechanism of regulation of the F-ATPase between the host and the parasite could be exploited in the design of drugs to combat human and animal African trypanosomiases.
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a zvířata $7 D000818
650    _2
$a skot $7 D002417
650    _2
$a inhibitory enzymů $x chemie $x farmakologie $7 D004791
650    12
$a regulace genové exprese $7 D005786
650    _2
$a mutace $7 D009154
650    _2
$a proteiny $x chemie $x genetika $x farmakologie $7 D011506
650    _2
$a protonové ATPasy $x antagonisté a inhibitory $7 D006180
650    _2
$a sekvenční homologie $7 D017385
650    _2
$a Trypanosoma brucei brucei $x enzymologie $7 D014346
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Panicucci, Brian $u Institute of Parasitology, Biology Centre Czech Academy of Science, České Budějovice, Czech Republic.
700    1_
$a Váchová, Hana $u Institute of Parasitology, Biology Centre Czech Academy of Science, České Budějovice, Czech Republic.
700    1_
$a Walker, John E $u The Medical Research Council Mitochondrial Biology Unit, University of Cambridge, UK.
700    1_
$a Zíková, Alena $u Institute of Parasitology, Biology Centre Czech Academy of Science, České Budějovice, Czech Republic. Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
773    0_
$w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 285, č. 23 (2018), s. 4413-4423
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30288927 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190819100152 $b ABA008
999    __
$a ok $b bmc $g 1433319 $s 1066630
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 285 $c 23 $d 4413-4423 $e 20181017 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
GRA    __
$a MC_U105663150 $p Medical Research Council $2 United Kingdom
GRA    __
$a MC_EX_MR/M009858/1 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...